Basit öğe kaydını göster

dc.contributor.authorTanakol, R
dc.contributor.authorDizdaroglu, F
dc.contributor.authorTerzioglu, T
dc.contributor.authorAlagol, F
dc.contributor.authorAzizlerli, H
dc.date.accessioned2021-03-05T10:43:28Z
dc.date.available2021-03-05T10:43:28Z
dc.date.issued1997
dc.identifier.citationAzizlerli H., Tanakol R., Terzioglu T., Alagol F., Dizdaroglu F., "Steroid cell tumor of the ovary as a rare cause of virilization", MOUNT SINAI JOURNAL OF MEDICINE, cilt.64, ss.130-135, 1997
dc.identifier.issn0027-2507
dc.identifier.othervv_1032021
dc.identifier.otherav_a49f8cb7-5381-4303-a13e-fda1939e7a2c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/110118
dc.description.abstractBackground: Virilization is associated with either ovarian causes, including polycystic ovary syndrome, hyperthecosis, and ovarian tumor, or with adrenal causes, including tumors and congenital adrenal hyperplasia. In establishing the diagnosis, levels of dehydroepiandresterone sulfate, testosterone, and 17 alpha-hydroxyprogesterone (17-OHP), with their response to dexamethasone treatment, should be assessed; and, where indicated, computerized tomography, ultrasound, and selective venous catheterization should be undertaken.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleSteroid cell tumor of the ovary as a rare cause of virilization
dc.typeMakale
dc.relation.journalMOUNT SINAI JOURNAL OF MEDICINE
dc.contributor.department, ,
dc.identifier.volume64
dc.identifier.issue2
dc.identifier.startpage130
dc.identifier.endpage135
dc.contributor.firstauthorID118556


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster